BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 8824867)

  • 1. Emergence of nalidixic acid resistant Shigella dysenteriae type 1 in Thailand: an outbreak associated with consumption of a coconut milk dessert.
    Hoge CW; Bodhidatta L; Tungtaem C; Echeverria P
    Int J Epidemiol; 1995 Dec; 24(6):1228-32. PubMed ID: 8824867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outbreak of dysentery due to nalidixic acid resistant S. dysenteriae 1 at Agartala, Tripura: a hospital based study.
    Datta P; Sen D
    Indian J Public Health; 1990; 34(1):11-4. PubMed ID: 2101382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nalidixic acid-resistant Shigella dysenteriae type I in KwaZulu-Natal.
    Karas JA; Pillay DG
    S Afr Med J; 1996 Jan; 86(1):93. PubMed ID: 8685796
    [No Abstract]   [Full Text] [Related]  

  • 4. Introduction and spread of multi-resistant Shigella dysenteriae I in Thailand.
    Taylor DN; Bodhidatta L; Brown JE; Echeverria P; Kunanusont C; Naigowit P; Hanchalay S; Chatkaeomorakot A; Lindberg AA
    Am J Trop Med Hyg; 1989 Jan; 40(1):77-85. PubMed ID: 2644859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nalidixic-acid resistant Shigella dysenteriae type 1 in eastern India.
    Sen D; Dutta P; Deb BC; Pal SC
    Lancet; 1988 Oct; 2(8616):911. PubMed ID: 2902361
    [No Abstract]   [Full Text] [Related]  

  • 6. Unusual association of a plasmid with nalidixic acid resistance in an epidemic strain of Shigella dysenteriae type 1 from Asia.
    Ashraf MM; Ahmed ZU; Sack DA
    Can J Microbiol; 1991 Jan; 37(1):59-63. PubMed ID: 2021898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemic Shigella dysenteriae type 1 in Burundi: panresistance and implications for prevention.
    Ries AA; Wells JG; Olivola D; Ntakibirora M; Nyandwi S; Ntibakivayo M; Ivey CB; Greene KD; Tenover FC; Wahlquist SP
    J Infect Dis; 1994 May; 169(5):1035-41. PubMed ID: 8169388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple drug-resistant Shigella dysenteriae type 1 in Rajbari district, Bangladesh.
    Jahan Y; Hossain A
    J Diarrhoeal Dis Res; 1997 Mar; 15(1):17-20. PubMed ID: 9308296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistant epidemic shigellosis in a village in west Bengal, 1984.
    Sengupta PG; Mandal S; Sen D; Das P; Deb BC; Pal SC
    Indian J Public Health; 1990; 34(1):15-9. PubMed ID: 2101383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiological investigation of diarrhoea epidemics among Rwandan refugees in Zaire.
    Islam MS; Siddique AK; Salam A; Akram K; Majumdar RN; Zaman K; Fronczak N; Laston S
    Trans R Soc Trop Med Hyg; 1995; 89(5):506. PubMed ID: 8560524
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidemic shigella dysentery in children in northern KwaZulu-Natal.
    Chopra M; Wilkinson D; Stirling S
    S Afr Med J; 1997 Jan; 87(1):48-51. PubMed ID: 9063314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An outbreak of Shigella dysenteriae type 1 dysentery in a refugee camp in Rwanda].
    Paquet C; Leborgne P; Sasse A; Varaine F
    Sante; 1995; 5(3):181-4. PubMed ID: 7640901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility of Shigella flexneri and S. dysenteriae isolated from stool specimens of patients with bloody diarrhoea in Mwanza, Tanzania.
    Temu MM; Kaatano GM; Miyaye ND; Buhalata SN; Shushu ML; Kishamawe C; Changalucha JM
    Tanzan Health Res Bull; 2007 Sep; 9(3):186-9. PubMed ID: 18087897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1.
    Munshi MH; Sack DA; Haider K; Ahmed ZU; Rahaman MM; Morshed MG
    Lancet; 1987 Aug; 2(8556):419-21. PubMed ID: 2887725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmid characterization of drug-resistant Shigella dysenteriae 1 from an epidemic in Central Africa.
    Frost JA; Willshaw GA; Barclay EA; Rowe B; Lemmens P; Vandepitte J
    J Hyg (Lond); 1985 Apr; 94(2):163-72. PubMed ID: 3886782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shigella dysenteriae serotype 1, Kolkata, India.
    Dutta S; Dutta S; Dutta P; Matsushita S; Bhattacharya SK; Yoshida S
    Emerg Infect Dis; 2003 Nov; 9(11):1471-4. PubMed ID: 14718096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology.
    von Seidlein L; Kim DR; Ali M; Lee H; Wang X; Thiem VD; Canh DG; Chaicumpa W; Agtini MD; Hossain A; Bhutta ZA; Mason C; Sethabutr O; Talukder K; Nair GB; Deen JL; Kotloff K; Clemens J
    PLoS Med; 2006 Sep; 3(9):e353. PubMed ID: 16968124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing incidence of antibiotic resistance in shigellas from humans in England and Wales: recommendations for therapy.
    Cheasty T; Skinner JA; Rowe B; Threlfall EJ
    Microb Drug Resist; 1998; 4(1):57-60. PubMed ID: 9533726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemic dysentery caused by Shigella dysenteriae type 1: a sentinel site surveillance of antimicrobial resistance patterns in Burundi.
    Engels D; Madaras T; Nyandwi S; Murray J
    Bull World Health Organ; 1995; 73(6):787-91. PubMed ID: 8907772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nalidixic-acid-resistant Shigella dysenteriae I.
    Panhotra BR; Desai B; Sharma PL
    Lancet; 1985 Mar; 1(8431):763. PubMed ID: 2858035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.